Critical Role of Spns2, a Sphingosine-1-phosphate Transporter, in Lung Cancer Cell Survival and Migration

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2014 Oct 21

PMID 25330231

Citations 35

Authors

Eric Bradley

Somsankar Dasgupta

Xue Jiang

Xiaying Zhao

Gu Zhu

Qian He

Michael Dinkins

Erhard Bieberich

Guanghu Wang

Affiliations

Soon will be listed here.

Abstract

The sphingosine-1-phosphate (S1P) transporter Spns2 regulates myocardial precursor migration in zebrafish and lymphocyte trafficking in mice. However, its function in cancer has not been investigated. We show here that ectopic Spns2 expression induced apoptosis and its knockdown enhanced cell migration in non-small cell lung cancer (NSCLC) cells. Metabolically, Spns2 expression increased the extracellular S1P level while its knockdown the intracellular. Pharmacological inhibition of S1P synthesis abolished the augmented cell migration mediated by Spns2 knockdown, indicating that intracellular S1P plays a key role in this process. Cell signaling studies indicated that Spns2 expression impaired GSK-3β and Stat3 mediated pro-survival pathways. Conversely, these pathways were activated by Spns2 knockdown, which explains the increased cell migration since they are also crucial for migration. Alterations of Spns2 were found to affect several enzymes involved in S1P metabolism, including sphingosine kinases, S1P phosphatases, and S1P lyase 1. Genetically, Spns2 mRNA level was found to be reduced in advanced lung cancer (LC) patients as quantified by using a small scale qPCR array. These data show for the first time that Spns2 plays key roles in regulating the cellular functions in NSCLC cells, and that its down-regulation is a potential risk factor for LC.

Citing Articles

Sphingosine-1-Phosphate Metabolic Pathway in Cancer: Implications for Therapeutic Targets.

Rufail M, Bassi R, Giussani P Int J Mol Sci. 2025; 26(3).

PMID: 39940821 PMC: 11817292. DOI: 10.3390/ijms26031056.

METTL3 as a novel diagnosis and treatment biomarker and its association with glycolysis, cuproptosis and ceRNA in oesophageal carcinoma.

Liu X, Zhang Y, Liu Z, Gao Y, Yuan L, Zeng D J Cell Mol Med. 2024; 28(6):e18195.

PMID: 38429907 PMC: 10907846. DOI: 10.1111/jcmm.18195.

Small Molecular Inhibitors Reverse Cancer Metastasis by Blockading Oncogenic PITPNM3.

Liu Z, Shi Y, Lv L, Chen J, Jiang W, Li J Adv Sci (Weinh). 2022; 9(35):e2204649.

PMID: 36285700 PMC: 9762305. DOI: 10.1002/advs.202204649.

Inhibited The Progression of Triple Negative Breast Cancer via Targeting The Axis.

Wu G, Sun P, Qin C Cell J. 2022; 24(5):230-238.

PMID: 35717570 PMC: 9445519. DOI: 10.22074/cellj.2022.8024.

Interaction of microRNAs with sphingosine kinases, sphingosine-1 phosphate, and sphingosine-1 phosphate receptors in cancer.

Xu G, Yang Z, Sun Y, Dong H, Ma J Discov Oncol. 2022; 12(1):33.

PMID: 35201458 PMC: 8777508. DOI: 10.1007/s12672-021-00430-9.

References

Wang G, Dinkins M, He Q, Zhu G, Poirier C, Campbell A . Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4): potential mechanism of apoptosis induction in Alzheimer disease (AD). J Biol Chem. 2012; 287(25):21384-95. PMC: 3375560. DOI: 10.1074/jbc.M112.340513. View

Chalfant C, Spiegel S . Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling. J Cell Sci. 2005; 118(Pt 20):4605-12. DOI: 10.1242/jcs.02637. View

Takuwa N, Du W, Kaneko E, Okamoto Y, Yoshioka K, Takuwa Y . Tumor-suppressive sphingosine-1-phosphate receptor-2 counteracting tumor-promoting sphingosine-1-phosphate receptor-1 and sphingosine kinase 1 - Jekyll Hidden behind Hyde. Am J Cancer Res. 2011; 1(4):460-81. PMC: 3186046. View

Osborne N, Brand-Arzamendi K, Ober E, Jin S, Verkade H, Holtzman N . The spinster homolog, two of hearts, is required for sphingosine 1-phosphate signaling in zebrafish. Curr Biol. 2008; 18(23):1882-8. PMC: 2741689. DOI: 10.1016/j.cub.2008.10.061. View

Huang Y, Huang W, Lee H . Roles of sphingosine 1-phosphate on tumorigenesis. World J Biol Chem. 2011; 2(2):25-34. PMC: 3083992. DOI: 10.4331/wjbc.v2.i2.25. View

Nijnik A, Clare S, Hale C, Chen J, Raisen C, Mottram L . The role of sphingosine-1-phosphate transporter Spns2 in immune system function. J Immunol. 2012; 189(1):102-11. PMC: 3381845. DOI: 10.4049/jimmunol.1200282. View

Nagahashi M, Kim E, Yamada A, Ramachandran S, Allegood J, Hait N . Spns2, a transporter of phosphorylated sphingoid bases, regulates their blood and lymph levels, and the lymphatic network. FASEB J. 2012; 27(3):1001-11. PMC: 3574288. DOI: 10.1096/fj.12-219618. View

Yano A, Tsutsumi S, Soga S, Lee M, Trepel J, Osada H . Inhibition of Hsp90 activates osteoclast c-Src signaling and promotes growth of prostate carcinoma cells in bone. Proc Natl Acad Sci U S A. 2008; 105(40):15541-6. PMC: 2563126. DOI: 10.1073/pnas.0805354105. View

Cuvillier O . Downregulating sphingosine kinase-1 for cancer therapy. Expert Opin Ther Targets. 2008; 12(8):1009-20. DOI: 10.1517/14728222.12.8.1009. View

10.

Brizuela L, Ader I, Mazerolles C, Bocquet M, Malavaud B, Cuvillier O . First evidence of sphingosine 1-phosphate lyase protein expression and activity downregulation in human neoplasm: implication for resistance to therapeutics in prostate cancer. Mol Cancer Ther. 2012; 11(9):1841-51. DOI: 10.1158/1535-7163.MCT-12-0227. View

11.

Shepherd F, Pereira J, Ciuleanu T, Tan E, Hirsh V, Thongprasert S . Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med. 2005; 353(2):123-32. DOI: 10.1056/NEJMoa050753. View

12.

Bradley E, Bieberich E, Mivechi N, Tangpisuthipongsa D, Wang G . Regulation of embryonic stem cell pluripotency by heat shock protein 90. Stem Cells. 2012; 30(8):1624-33. PMC: 3665290. DOI: 10.1002/stem.1143. View

13.

Berdyshev E, Gorshkova I, Usatyuk P, Kalari S, Zhao Y, Pyne N . Intracellular S1P generation is essential for S1P-induced motility of human lung endothelial cells: role of sphingosine kinase 1 and S1P lyase. PLoS One. 2011; 6(1):e16571. PMC: 3031585. DOI: 10.1371/journal.pone.0016571. View

14.

Wang G, Krishnamurthy K, Umapathy N, Verin A, Bieberich E . The carboxyl-terminal domain of atypical protein kinase Czeta binds to ceramide and regulates junction formation in epithelial cells. J Biol Chem. 2009; 284(21):14469-75. PMC: 2682895. DOI: 10.1074/jbc.M808909200. View

15.

Looyenga B, Hutchings D, Cherni I, Kingsley C, Weiss G, MacKeigan J . STAT3 is activated by JAK2 independent of key oncogenic driver mutations in non-small cell lung carcinoma. PLoS One. 2012; 7(2):e30820. PMC: 3271110. DOI: 10.1371/journal.pone.0030820. View

16.

Spiegel S, Milstien S . The outs and the ins of sphingosine-1-phosphate in immunity. Nat Rev Immunol. 2011; 11(6):403-15. PMC: 3368251. DOI: 10.1038/nri2974. View

17.

West L, Vidwans S, Campbell N, Shrager J, Simon G, Bueno R . A novel classification of lung cancer into molecular subtypes. PLoS One. 2012; 7(2):e31906. PMC: 3283716. DOI: 10.1371/journal.pone.0031906. View

18.

Kawahara A, Nishi T, Hisano Y, Fukui H, Yamaguchi A, Mochizuki N . The sphingolipid transporter spns2 functions in migration of zebrafish myocardial precursors. Science. 2008; 323(5913):524-7. DOI: 10.1126/science.1167449. View

19.

Nakata A, Gotoh N . Recent understanding of the molecular mechanisms for the efficacy and resistance of EGF receptor-specific tyrosine kinase inhibitors in non-small cell lung cancer. Expert Opin Ther Targets. 2012; 16(8):771-81. DOI: 10.1517/14728222.2012.697155. View

20.

Maceyka M, Harikumar K, Milstien S, Spiegel S . Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol. 2011; 22(1):50-60. PMC: 3253987. DOI: 10.1016/j.tcb.2011.09.003. View